What's breaking now, across thousands of outlets.
(RTTNews) - Wednesday, AEON Biopharma (AEON) said FDA feedback from a Type 2b meeting provided clarity on the development pathway for ABP-450 as a biosimilar to BOTOX.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
We have put together stories from our coverage of the Xi-Trump summit. If you would like to see more of our reporting, please consider subscribing. 1. Why Xi Jinping skipped the UN after his Trump summit Han Zheng, China’s vice-president, called on “major countries” to respect the sovereignty and security of Middle Eastern nations and…
We are reminded seemingly daily of the great power transitions that ended in conflict. However, it is the exceptions – the ones that did not result in war – that could have real lessons to offer. Today, the question is more than academic.
Real gross domestic product (GDP) increased at an annual rate of 2.2 percent in the second quarter of 2026 (April, May, and June), according to the third estimate released today by the U.S.
Bain projects holiday sales will top $1 trillion for the first time, but more than half of that nominal growth will come from higher prices
Personal income increased $66.6 billion (0.2 percent at a monthly rate) in August, according to estimates released today by the U.S. Bureau of Economic Analysis (BEA).
The Union Cabinet approved the ₹1.86 lakh crore PM-DHARA scheme to strengthen intra-state power transmission and evacuate up to 135 GW of renewable energy. It includes 50 GWh of battery storage, with ₹54,082 crore in central support to reduce transmission costs and power prices.
